Citations (26)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (8)
Simone Baiardi, Angela Mammana, Sabina Capellari & Piero Parchi. (2023) Human prion disease: molecular pathogenesis, and possible therapeutic targets and strategies. Expert Opinion on Therapeutic Targets 0:0, pages 1-14.
Read now
Read now
Utpal Kumar Adhikari & Mourad Tayebi. (2021) Epitope-specific anti-PrP antibody toxicity: a comparative in-silico study of human and mouse prion proteins. Prion 15:1, pages 155-176.
Read now
Read now
Alex J. McDonald, Bei Wu & David A. Harris. (2017) An inter-domain regulatory mechanism controls toxic activities of PrPC. Prion 11:6, pages 388-397.
Read now
Read now
Huiying Gu, Richard C Dodel, Martin R Farlow & Yansheng Du. (2014) Advances in the development of antibody-based immunotherapy against prion disease. Antibody Technology Journal 4, pages 45-55.
Read now
Read now
Thomas Wisniewski & Fernando Goñi. (2012) Could immunomodulation be used to prevent prion diseases?. Expert Review of Anti-infective Therapy 10:3, pages 307-317.
Read now
Read now
Thomas Wisniewski & Fernando Goñi. (2010) Immunomodulation for prion and prion-related diseases. Expert Review of Vaccines 9:12, pages 1441-1452.
Read now
Read now
Suehiro Sakaguchi, Daisuke Ishibashi & Haruo Matsuda. (2009) Antibody-based immunotherapeutic attempts in experimental animal models of prion diseases. Expert Opinion on Therapeutic Patents 19:7, pages 907-917.
Read now
Read now
Marcus W Brazier, Vanessa A Wall, Barry W Brazier, Colin L Masters & Steven J Collins. (2009) Therapeutic interventions ameliorating prion disease. Expert Review of Anti-infective Therapy 7:1, pages 83-105.
Read now
Read now
Articles from other publishers (18)
Scott Napper & Hermann M. Schatzl. (2023) Oral vaccination as a potential strategy to manage chronic wasting disease in wild cervid populations. Frontiers in Immunology 14.
Crossref
Crossref
Scott Napper & Hermann M. Schatzl. (2023) Vaccines for prion diseases: a realistic goal?. Cell and Tissue Research 392:1, pages 367-392.
Crossref
Crossref
Mohsin Shafiq, Stefano Da Vela, Ladan Amin, Neelam Younas, David A. Harris, Inga Zerr, Hermann C. Altmeppen, Dmitri Svergun & Markus Glatzel. (2022) The prion protein and its ligands: Insights into structure-function relationships. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research 1869:6, pages 119240.
Crossref
Crossref
Utpal Kumar Adhikari, Elif Sakiz, Xian Zhou, Umma Habiba, Sachin Kumar, Meena Mikhael, Matteo Senesi, Chun Guang Li, Gilles J. Guillemin, Lezanne Ooi, Monique Antoinette David, Steven Collins, Tim Karl & Mourad Tayebi. (2021) Cross-Linking Cellular Prion Protein Induces Neuronal Type 2-Like Hypersensitivity. Frontiers in Immunology 12.
Crossref
Crossref
Cao Chen & Xiaoping Dong. (2021) Therapeutic implications of prion diseases. Biosafety and Health 3:2, pages 92-100.
Crossref
Crossref
Yue Ma & Jiyan Ma. (2020) Immunotherapy against Prion Disease. Pathogens 9:3, pages 216.
Crossref
Crossref
Sara A.M. Holec, Alyssa J. Block & Jason C. Bartz. 2020. Prions and Neurodegenerative Diseases. Prions and Neurodegenerative Diseases
77
119
.
Silvia A. Purro, Simon Mead, Azadeh Khalili-Shirazi, Andrew J. Nicoll & John Collinge. (2018) Reply to: Intrinsic Toxicity of Antibodies to the Globular Domain of the Prion Protein. Biological Psychiatry 84:7, pages e53-e54.
Crossref
Crossref
Regina R. Reimann & Adriano Aguzzi. (2018) Intrinsic Toxicity of Antibodies to the Globular Domain of the Prion Protein. Biological Psychiatry 84:7, pages e51-e52.
Crossref
Crossref
Adriano AguzziAsvin K.K. LakkarajuKarl Frontzek. (2018) Toward Therapy of Human Prion Diseases. Annual Review of Pharmacology and Toxicology 58:1, pages 331-351.
Crossref
Crossref
Regina R. Reimann, Tiziana Sonati, Simone Hornemann, Uli S. Herrmann, Michael Arand, Simon Hawke & Adriano Aguzzi. (2016) Differential Toxicity of Antibodies to the Prion Protein. PLOS Pathogens 12:1, pages e1005401.
Crossref
Crossref
Adriano Aguzzi, Mario Nuvolone & Caihong Zhu. (2013) The immunobiology of prion diseases. Nature Reviews Immunology 13:12, pages 888-902.
Crossref
Crossref
Thomas Wisniewski & Fernando Goñi. 2013. Prions and Diseases. Prions and Diseases
269
287
.
T. Dean Airey & Neil R. Cashman. 2013. Prions and Diseases. Prions and Diseases
233
255
.
Sabrina Cronier, Julie Carimalo, Brigitte Schaeffer, Emilie Jaumain, Vincent Béringue, Marie‐Christine Miquel, Hubert Laude & Jean‐Michel Peyrin. (2012) Endogenous prion protein conversion is required for prion‐induced neuritic alterations and neuronal death. The FASEB Journal 26:9, pages 3854-3861.
Crossref
Crossref
Giuseppe Scalabrino, Elena Mutti, Daniela Veber, Virginia Rodriguez Menendez, Cristina Novembrino, Alberto Calligaro & Giovanni Tredici. (2011)
The octapeptide repeat PrP
C
region and cobalamin-deficient polyneuropathy of the rat
. Muscle & Nerve 44:6, pages 957-967.
Crossref
Crossref
Daisuke Ishibashi, Hitoki Yamanaka, Tsuyoshi Mori, Naohiro Yamaguchi, Yoshitaka Yamaguchi, Noriyuki Nishida & Suehiro Sakaguchi. (2011) Antigenic mimicry-mediated anti-prion effects induced by bacterial enzyme succinylarginine dihydrolase in mice. Vaccine 29:50, pages 9321-9328.
Crossref
Crossref
Koji Fujita, Yoshitaka Yamaguchi, Tsuyoshi Mori, Naomi Muramatsu, Takahito Miyamoto, Masashi Yano, Hironori Miyata, Akira Ootsuyama, Makoto Sawada, Haruo Matsuda, Ryuji Kaji & Suehiro Sakaguchi. (2011) Effects of a Brain-Engraftable Microglial Cell Line Expressing Anti-Prion scFv Antibodies on Survival Times of Mice Infected with Scrapie Prions. Cellular and Molecular Neurobiology 31:7, pages 999-1008.
Crossref
Crossref